ro 22-0654 has been researched along with Obesity in 4 studies
*Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sullivan, AC; Triscari, J | 2 |
| Hogan, S; Sullivan, AC; Triscari, J | 1 |
| Chapman, BJ; Munro, JF; Stewart, IC | 1 |
1 review(s) available for ro 22-0654 and Obesity
| Article | Year |
|---|---|
New developments in pharmacological treatments for obesity.
Topics: 2-Hydroxyphenethylamine; Animals; Appetite; Energy Intake; Energy Metabolism; Humans; Obesity; Oxygen Consumption; Thiophenes | 1987 |
1 trial(s) available for ro 22-0654 and Obesity
| Article | Year |
|---|---|
Pharmacological approaches to the regulation of fat metabolism.
Topics: 2-Hydroxyphenethylamine; Animals; Appetite Depressants; Clinical Trials as Topic; Ethanolamines; Humans; Hypolipidemic Agents; Lipids; Obesity; Rats; Thiophenes; Thyroid Hormones | 1986 |
2 other study(ies) available for ro 22-0654 and Obesity
| Article | Year |
|---|---|
Anti-obesity activity of a novel lipid synthesis inhibitor.
Topics: Adipose Tissue; Animals; Fatty Acids; Female; Lipid Metabolism; Lipids; Lipolysis; Liver Glycogen; Obesity; Oxidation-Reduction; Rats; Rats, Inbred Strains; Rats, Zucker; Thiophenes | 1984 |
Antiobesity effects of a novel lipid synthesis inhibitor (Ro 22-0654).
Topics: Animals; Body Weight; Eating; Energy Metabolism; Fatty Acids; Female; Liver; Male; Obesity; Rats; Rats, Inbred Strains; Thiophenes | 1984 |